Neuro-Oncology Reviews

Volume 24 Number 22
30 November 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 22, 30 November

Low JJW, Sulaiman SA, Johdi NA, Abu N.
Immunomodulatory effects of extracellular vesicles in glioblastoma.
Front Cell Dev Biol. 2022 Nov 16, 2022;10:996805
. doi: 10.3389/fcell.2022.996805. PMID: 36467419. Review.

Lei Q, Yang Y, Zhou W, Liu W, Li Y, Qi N, Li Q, Wen Z, Ding L, Huang X, Li Y, Wu J.
MicroRNA-based therapy for glioblastoma: Opportunities and challenges.
Eur J Pharmacol. 2022 Nov 17, 2022:175388. doi: 10.1016/j.ejphar.2022.175388. PMID: 36403686. Review.

Zhang X, Zhao L, Zhang H, Zhang Y, Ju H, Wang X, Ren H, Zhu X, Dong Y.
The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
Front Immunol. 2022 Nov 17, 2022;13:1003651
. doi: 10.3389/fimmu.2022.1003651. PMID: 36466873. Review.

Kerezoudis P, Kerezoudi EN, Choudhry A, Himes BT, Parney IF.
Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature.
Neurosurgery. 2022 Nov 18
. doi: 10.1227/neu.0000000000002236. PMID: 36650046. Review˰

Sletvold TP, Boland S, Schipmann S, Mahesparan R.
Quality indicators for evaluating the 30-day postoperative outcome in pediatric brain tumor surgery: a 10-year single-center study and systematic review of the literature.
J Neurosurg Pediatr. 2022 Nov 18, 2022:1-15. doi: 10.3171/2022.10.PEDS22308. PMID: 36401544. Observational study, Review˰

Pachocki CJ, Hol EM.
Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
J Neuroinflammation. 2022 Nov 19, 2022;19(1):276. doi: 10.1186/s12974-022-02630-8. PMID: 36403059. Review.

Caffarel MM, Braza MS.
Microglia and metastases to the central nervous system: victim, ravager, or something else?
J Exp Clin Cancer Res. 2022 Nov 21, 2022;41(1):327. doi: 10.1186/s13046-022-02535-7. PMID: 36411434. Review.

Chanbour H, Chotai S.
Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes.
Cancers (Basel). 2022 Nov 21, 2022;14(22):5705. doi: 10.3390/cancers14225705. PMID: 36428797. Review.

Deng Q, Tao S, Huang H, Lv Q, Wang W.
Chloroquine Supplementation for the Treatment of Glioblastoma: A Meta-analysis of Randomized Controlled Studies.
Clin Neuropharmacol. 2022 Nov 21. doi: 10.1097/WNF.0000000000000533. PMID: 36409625. Meta-analysis˰

Sae-Huang M, Smith LC, Usher I, Hill CS.
Cystic glioblastoma: A systematic review and meta-analysis of characteristics and outcomes.
Brain Spine. 2022 Nov 21, 2022;2:101692
. doi: 10.1016/j.bas.2022.101692. PMID: 36605383. Review, Meta-analysis.

Rao P, Furst L, Meyran D, Mayoh C, Neeson PJ, Terry R, Khuong-Quang DA, Mantamadiotis T, Ekert PG.
Advances in CAR T cell immunotherapy for paediatric brain tumours.
Front Oncol. 2022 Nov 23, 2022;12:873722
. doi: 10.3389/fonc.2022.873722. PMID: 36505819. Review.

Qiu Z, Yu Z, Xu T, Wang L, Meng N, Jin H, Xu B.
Novel Nano-Drug Delivery System for Brain Tumor Treatment.
Cells. 2022 Nov 24, 2022;11(23):3761
. doi: 10.3390/cells11233761. PMID: 36497021. Review.

Roach JR, Plaha P, McGowan DR, Higgins GS.
The role of [18F]fluorodopa positron emission tomography in grading of gliomas.
J Neurooncol. 2022 Nov 24. doi: 10.1007/s11060-022-04177-3. PMID: 36434486. Review.

Sallam M, Mysara M, Baatout S, Guns PJ, Ramadan R, Benotmane MA.
Meta-Analysis of RNA-Seq Datasets Identifies Novel Players in Glioblastoma.
Cancers (Basel). 2022 Nov 24, 2022;14(23):5788
. doi: 10.3390/cancers14235788. PMID: 36497269. Meta-analysis.

Zhang M, Lei Q, Huang X, Wang Y.
Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma.
Front Pharmacol. 2022 Nov 24, 2022;13:1071897
. doi: 10.3389/fphar.2022.1071897. PMID: 36506514. Review.


Rath A, Mohanty DK, Prasad Mishra BS, Bagal DK.
A Bibliometric Review: Brain Tumour MRIs using different CNN Architectures.
World Neurosurg. 2022 Nov 25, 2022:S1878-8750(22)01642-4. doi: 10.1016/j.wneu.2022.11.091. PMID: 36442778. Bibliometric analysis˰

Tejada Solís S, González Sánchez J, Iglesias Lozano I, Plans Ahicart G, Pérez Núñez A, Meana Carballo L, Gil Salú JL, Fernández Coello A, García Romero JC, Rodríguez de Lope Llorca A, García Duque S, Díez Valle R, Narros Giménez JL, Prat Acín R; Working Group of the SENEC.
Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.
Neurocirugia (Astur). 2022 Nov 26:S2529-8496(22)00076-4. doi: 10.1016/j.neucie.2022.11.006. PMID: 36446721. Guidelines˰

Frosina G.
Most recent update of preclinical and clinical data on radioresistance and radiosensitivity of high-grade gliomas-a radiation oncologist's perspective.
Strahlenther Onkol. 2022 Nov 29. doi: 10.1007/s00066-022-02020-2. PMID: 36445383. Review˰

Qi D, Li J, Quarles CC, Fonkem E, Wu E.
Assessment and prediction of glioblastoma therapy response: challenges and opportunities.
Brain. 2022 Nov 29, 2022:awac450. doi: 10.1093/brain/awac450. PMID: 36445396. Review˰